AD Ports Group and Hayat Biotech signed a Memorandum of Understanding (MoU) to support Hayat Biotech’s global logistics and distribution efforts through AD Ports Group’s advanced pharma logistics network, which includes its cold and ultra-cold pharma hub based in KIZAD. 

The partnership will help facilitate Hayat Biotech’s efforts to set up manufacturing centres around the globe and provide logistics solutions to serve its international markets.

The initial element of the agreement encapsulates the shipping of strategic construction supplies, including containers, machinery, raw materials, and equipment, to support the construction of Hayat Biotech’s global biopharmaceutical manufacturing facilities.

Once fully completed, the facilities will produce several vital biopharmaceutical products, including the Hayat-Vax vaccine, the first indigenously produced COVID-19 vaccine in the UAE and the Arab world.

As part of the collaboration, the distribution will be handled by the HOPE Consortium, an Abu Dhabi-led partnership which operates one of the largest and most complete end-to-end pharma supply chains on the market.